Recommended dose of PDX given in combination with a fixed dose of 5-FU administered as a 48-hour infusion given every other week During the initial course [clinicaltrials_resource:a8ace48d8250cb8da2bed760af733bdf]
Maximum tolerated dose will have been exceeded when 2 patients entered at a given dose level experience specified dose-limiting toxicities in the initial cycle.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Recommended dose of PDX given in combination with a fixed dose of 5-FU administered as a 48-hour infusion given every other week During the initial course [clinicaltrials_resource:a8ace48d8250cb8da2bed760af733bdf]
Maximum tolerated dose will have been exceeded when 2 patients entered at a given dose level experience specified dose-limiting toxicities in the initial cycle.
Bio2RDF identifier
a8ace48d8250cb8da2bed760af733bdf
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a8ace48d8250cb8da2bed760af733bdf
measure [clinicaltrials_vocabulary:measure]
Recommended dose of PDX given ...... nfusion given every other week
time frame [clinicaltrials_vocabulary:time-frame]
During the initial course
description
Maximum tolerated dose will ha ...... xicities in the initial cycle.
identifier
clinicaltrials_resource:a8ace48d8250cb8da2bed760af733bdf
title
Recommended dose of PDX given ...... week During the initial course
@en
type
label
Recommended dose of PDX given ...... ce48d8250cb8da2bed760af733bdf]
@en